✦ LIBER ✦

A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma

✍ Scribed by Mark S. Talamonti; William Small; Mary F. Mulcahy; Jeffrey D. Wayne; Vikram Attaluri; Lisa M. Colletti; Mark M. Zalupski; John P. Hoffman; Gary M. Freedman; Timothy J. Kinsella; Philip A. Philip; Cornelius J. McGinn

Book ID: 111771575
Publisher: Springer
Year: 2006
Tongue: English
Weight: 298 KB
Volume: 13
Category: Article
ISSN: 1068-9265
DOI: 10.1245/aso.2006.03.039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of combination therapy u

A phase I trial of combination therapy using gemcitabine and S-1 concurrent with full-dose radiation for resectable pancreatic cancer

✍ Eguchi, Hidetoshi; Nagano, Hiroaki; Kobayashi, Shogo; Kawamoto, Koichi; Wada, Hi 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 385 KB

Adjuvant gemcitabine and concurrent radi

Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study

✍ Blackstock, A W; Mornex, F; Partensky, C; Descos, L; Case, L D; Melin, S A; Levi 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 109 KB

A Multi-institute Retrospective Review o

A Multi-institute Retrospective Review of Concurrent Full-dose Gemcitabine With Radiation Versus Concurrent Fluorouracil With Radiation for Locally Advanced Pancreatic Cancer

✍ Rakhra, S.; Robertson, J.; McGinn, C.J.; Chung, A.; Huang, J.; Blake, A.; Heleno 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Quality of Life in a Prospective, Multic

Quality of Life in a Prospective, Multicenter Phase 2 Trial of Neoadjuvant Full-Dose Gemcitabine, Oxaliplatin, and Radiation in Patients With Resectable or Borderline Resectable Pancreatic Adenocarcinoma

✍ Serrano, Pablo E.; Herman, Joseph M.; Griffith, Kent A.; Zalupski, Mark M.; Kim, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 723 KB

A phase II trial of biweekly high dose g

A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma

✍ Herbert Ulrich-Pur; Gabriela V. Kornek; Markus Raderer; Karin Haider; Werner Kwa 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

A Phase I/II Trial of Intensity Modulate

A Phase I/II Trial of Intensity Modulated Radiation (IMRT) Dose Escalation With Concurrent Fixed-dose Rate Gemcitabine (FDR-G) in Patients With Unresectable Pancreatic Cancer

✍ Edgar Ben-Josef; Mathew Schipper; Isaac R. Francis; Scott Hadley; Randall Ten-Ha 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 306 KB